Gvs S.p.a · MIL:GVS
Gvs — Merger or Acquisition (May 2022)
7 slides from Gvs's merger presentation, May 13, 2022
Slide 1: Haemotronic Acquisition Presentation
GVS SPA 13.05.2022 HAEMOTRONIC ACQUISITION PRESENTATION
Slide 2: 17 M&A Transactions Since 2009
17 M&A TRANSACTIONS SINCE 2009 Adding capabilities and strengthening presence across China, the UK and North America Haemonetics Nypro M. BU Puerto Rico LLC Healthcare Healthcare Nhion Nypro Graphic Controls Laboratory Filtration Healthcare Remploy Personal safety Germa Filtration EPA Medical 2022 L
Slide 3: Haemotronic at a glance (1/2)
Haemotronic at a glance (1/2) Haemotronic is specialized producer of components and bags for the medical sector with plants in Italy (Mirandola and Borgocarbonara) and in Mexico (Reynosa). Overview Final Market Founded in 1979 in Mirandola (Italy) by the Ravizza family to Haemotronic's customers are
Slide 4: Haemotronic at a glance (2/2)
Haemotronic at a glance (2/2) Founded in 1979 in Mirandola (Italy) by the Ravizza family to support the family pharmaceutical business, Haemotronic has established itself over time as a world leader in the supply of disposable medical devices Haemotronic Footprint Italy Mexico • Plant in Reynosa, wh
Slide 5: Transaction Details
Transaction Details Price Full EV Earn Out Upfront EV 250 M€ on 38 M€ 212 M€ 2024 results • Cash & Debt Free Deal • The price for the acquisition of 100% of Haemotronic's share capital (the "Transaction") is € 212 million, corresponding to 15X Haemotronic's adjusted 2021 EV/EBIDTA, subject to post-
Slide 6: The rational for the deal and the opportunities from the integration
The rational for the deal and the opportunities from the integration The acquisition of Haemotronic represents a strong strategic opportunity for GVS growth. The acquisition of the company contributes to the growth of GVS's product portfolio which can thus integrate and expand the range of products
Slide 7: Disclaimer
DISCLAIMER This presentation contains certain forward-looking statements that reflect the Company’s management’s current views with respect to future events and financial and operational performance of the Company and its subsidiaries. These forward-looking statements are based on GVS S.p.A.’s curre